BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 27310960)

  • 1. Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis.
    Tan D; Fu Y; Su Q; Wang H
    Medicine (Baltimore); 2016 Jun; 95(24):e3837. PubMed ID: 27310960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
    Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
    Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
    Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
    Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
    Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
    Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis.
    Huang XZ; Chen WJ; Zhang X; Wu CC; Zhang CY; Sun SS; Wu J
    Dis Markers; 2017; 2017():1053125. PubMed ID: 28539688
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.
    Yodying H; Matsuda A; Miyashita M; Matsumoto S; Sakurazawa N; Yamada M; Uchida E
    Ann Surg Oncol; 2016 Feb; 23(2):646-54. PubMed ID: 26416715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of pretreatment platelet-to-lymphocyte ratio as predictors in patients with colorectal cancer: a meta-analysis.
    Min GT; Wang YH; Yao N; Zhao JM; Wang J; Wang HP; Chen W; Deng SJ; Li YM
    Biomark Med; 2017 Jan; 11(1):87-97. PubMed ID: 27917650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis.
    Zhang X; Zhao W; Yu Y; Qi X; Song L; Zhang C; Li G; Yang L
    World J Surg Oncol; 2020 Jul; 18(1):191. PubMed ID: 32731872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer.
    Zhu Y; Si W; Sun Q; Qin B; Zhao W; Yang J
    Oncotarget; 2017 Jan; 8(1):1023-1030. PubMed ID: 27906679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Platelet-to-Lymphocyte Ratio in Cholangiocarcinoma: A Meta-Analysis.
    Hu G; Liu Q; Ma JY; Liu CY
    Biomed Res Int; 2018; 2018():7375169. PubMed ID: 30539019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals.
    Guo W; Lu X; Liu Q; Zhang T; Li P; Qiao W; Deng M
    Cancer Med; 2019 Aug; 8(9):4135-4148. PubMed ID: 31197958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: A meta-analysis.
    Ma JY; Ke LC; Liu Q
    Medicine (Baltimore); 2018 Oct; 97(43):e12897. PubMed ID: 30412089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients.
    Li W; Tao L; Lu M; Xiu D
    Medicine (Baltimore); 2018 Feb; 97(8):e9616. PubMed ID: 29465553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-to-lymphocyte ratio associated with the clinicopathological features and prognostic value of breast cancer: A meta-analysis.
    Gong Z; Xin R; Li L; Lv L; Wu X
    Int J Biol Markers; 2022 Dec; 37(4):339-348. PubMed ID: 35971299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer.
    Baranyai Z; Krzystanek M; Jósa V; Dede K; Agoston E; Szász AM; Sinkó D; Szarvas V; Salamon F; Eklund AC; Szállási Z; Jakab F
    Thromb Haemost; 2014 Mar; 111(3):483-90. PubMed ID: 24285160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
    Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
    Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
    Ma W; Zhang P; Qi J; Gu L; Zang M; Yao H; Shi X; Wang C; Jiang Y
    Sci Rep; 2016 Oct; 6():35378. PubMed ID: 27739490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Breast Cancer: A Meta-Analysis.
    Zhang M; Huang XZ; Song YX; Gao P; Sun JX; Wang ZN
    Biomed Res Int; 2017; 2017():9503025. PubMed ID: 29082257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer.
    You J; Zhu GQ; Xie L; Liu WY; Shi L; Wang OC; Huang ZH; Braddock M; Guo GL; Zheng MH
    Oncotarget; 2016 May; 7(18):25516-27. PubMed ID: 27027440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.